| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 62.05B | 62.35B | 64.77B | 78.67B | 62.29B | 51.93B |
| Gross Profit | 13.60B | 13.99B | 7.17B | 22.57B | 19.86B | 13.56B |
| EBITDA | 11.93B | 12.52B | 6.53B | 20.65B | 17.84B | 12.44B |
| Net Income | 2.61B | 3.25B | -4.61B | 9.38B | 7.76B | 3.61B |
Balance Sheet | ||||||
| Total Assets | 123.35B | 123.62B | 125.30B | 130.76B | 109.90B | 92.32B |
| Cash, Cash Equivalents and Short-Term Investments | 17.79B | 20.29B | 25.41B | 22.36B | 26.73B | 23.68B |
| Total Debt | 36.16B | 37.88B | 41.68B | 37.79B | 30.91B | 26.96B |
| Total Liabilities | 56.60B | 55.99B | 59.72B | 61.98B | 49.99B | 39.90B |
| Stockholders Equity | 65.11B | 65.96B | 64.01B | 67.48B | 58.25B | 50.98B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.45B | 242.00M | -8.51B | 270.00M | 2.38B |
| Operating Cash Flow | 0.00 | 13.09B | 11.21B | 7.29B | 11.18B | 11.98B |
| Investing Cash Flow | 0.00 | -14.08B | -10.55B | -16.63B | -11.12B | -9.87B |
| Financing Cash Flow | 0.00 | -4.72B | 1.78B | 4.42B | 2.42B | 4.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥84.63B | 11.63 | 15.07% | 1.74% | 15.12% | 40.72% | |
77 Outperform | ¥119.27B | 10.07 | ― | 3.72% | 5.40% | 14.80% | |
76 Outperform | ¥79.99B | 6.04 | ― | 3.04% | 1.57% | -33.97% | |
76 Outperform | ¥90.44B | 7.61 | ― | 3.02% | 1.66% | 11.28% | |
69 Neutral | ¥90.65B | 9.79 | ― | 1.60% | 1.20% | ― | |
62 Neutral | ¥94.24B | 19.44 | ― | 1.30% | 47.56% | 49.58% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |